SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 19.54 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 25.12 |
| Book Value / Share | 0.55 |
| Price / Book | n/a |
| NCAV ($M) | 0.33 |
| NCAV / Share | 0.01 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.14 |
| Return on Assets (ROA) | -0.59 |
| Return on Equity (ROE) | -0.94 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.11 |
| Current Ratio | 2.32 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 20.74 |
| Assets | 45.53 |
| Liabilities | 20.41 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Charmquark TWEE | 5.80 | -41.62 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 112,899 | 245,976 | 45.90 | |
| 18,339 | 99,425 | 18.45 | |
| 87,953 | 565,479 | 15.55 | |
| 162,414 | 611,008 | 26.58 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| INMB – INmune Bio, Inc. | INO – Inovio Pharmaceuticals, Inc. |
| INTS – Intensity Therapeutics, Inc. | IRD – Opus Genetics, Inc. |
| ITRM – Iterum Therapeutics plc |
Financial data and stock pages provided by
Fintel.io